Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2025-12-25 @ 4:48 PM
Study NCT ID:
NCT03097003
Status:
COMPLETED
Last Update Posted:
2020-04-27
First Post:
2017-03-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of the Real-life Management of Psoriasis Patients Treated With Otezla® (Apremilast) in Belgium
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-06
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-20
Completion Date Type:
ACTUAL
First Submit Date:
2017-03-24
First Submit QC Date:
None
Study First Post Date:
2017-03-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-24
Last Update Post Date:
2020-04-27
Last Update Post Date Type:
ACTUAL